000			02320 a2200589 4500
005			20250515183554.0
264		0	_c20091217
008			200912s 0 0 eng d
022			_a1873-5177
024	7		_a10.1016/j.pbb.2009.08.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aManwell, Laurie A
245	0	0	_aFAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats. _h[electronic resource]
260			_bPharmacology, biochemistry, and behavior _cNov 2009
300			_a154-62 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAmidohydrolases _xantagonists & inhibitors
650	0	4	_aAnimals
650	0	4	_aBenzamides _xadministration & dosage
650	0	4	_aCannabinoid Receptor Modulators _xmetabolism
650	0	4	_aCarbamates _xadministration & dosage
650	0	4	_aChoice Behavior _xdrug effects
650	0	4	_aConditioning, Psychological
650	0	4	_aDietary Sucrose _xadministration & dosage
650	0	4	_aExtinction, Psychological _xdrug effects
650	0	4	_aFemale
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aInjections, Subcutaneous
650	0	4	_aMale
650	0	4	_aMorphine _xadverse effects
650	0	4	_aMorphine Dependence _xdrug therapy
650	0	4	_aNaloxone _xtherapeutic use
650	0	4	_aNarcotic Antagonists _xtherapeutic use
650	0	4	_aNarcotics _xadverse effects
650	0	4	_aPiperidines _xadministration & dosage
650	0	4	_aPyrazoles _xadministration & dosage
650	0	4	_aRats
650	0	4	_aRats, Long-Evans
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptor, Cannabinoid, CB1 _xagonists
650	0	4	_aReinforcement Schedule
650	0	4	_aRimonabant
650	0	4	_aSpecies Specificity
650	0	4	_aSubstance Withdrawal Syndrome
700	1		_aSatvat, Elham
700	1		_aLang, Stefan T
700	1		_aAllen, Craig P
700	1		_aLeri, Francesco
700	1		_aParker, Linda A
773	0		_tPharmacology, biochemistry, and behavior _gvol. 94 _gno. 1 _gp. 154-62
856	4	0	_uhttps://doi.org/10.1016/j.pbb.2009.08.002 _zAvailable from publisher's website
999			_c19100954 _d19100954